Literature DB >> 36157062

Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.

Jing Zhao1,2, Kaiying He1,2, Hongxuan Du1,2, Guohua Wei2, Yuejia Wen1,2, Jiaqi Wang1, Xiaochun Zhou2, Jianqin Wang2.   

Abstract

Background: Diabetic kidney disease (DKD) is the leading cause of death in people with type 2 diabetes mellitus (T2DM). The main objective of this study is to find the potential biomarkers for DKD. Materials and
Methods: Two datasets (GSE86300 and GSE184836) retrieved from Gene Expression Omnibus (GEO) database were used, combined with our RNA sequencing (RNA-seq) results of DKD mice (C57 BLKS-32w db/db) and non-diabetic (db/m) mice for further analysis. After processing the expression matrix of the three sets of data using R software "Limma", differential expression analysis was performed. The significantly differentially expressed genes (DEGs) (-logFC- > 1, p-value < 0.05) were visualized by heatmaps and volcano plots respectively. Next, the co-expression genes expressed in the three groups of DEGs were obtained by constructing a Venn diagram. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were further analyzed the related functions and enrichment pathways of these co-expression genes. Then, qRT-PCR was used to verify the expression levels of co-expression genes in the kidney of DKD and control mice. Finally, protein-protein interaction network (PPI), GO, KEGG analysis and Pearson correlation test were performed on the experimentally validated genes, in order to clarify the possible mechanism of them in DKD.
Results: Our RNA-seq results identified a total of 125 DEGs, including 59 up-regulated and 66 down-regulated DEGs. At the same time, 183 up-regulated and 153 down-regulated DEGs were obtained in GEO database GSE86300, and 76 up-regulated and 117 down-regulated DEGs were obtained in GSE184836. Venn diagram showed that 13 co-expression DEGs among the three groups of DEGs. GO analysis showed that biological processes (BP) were mainly enriched inresponse to stilbenoid, response to fatty acid, response to nutrient, positive regulation of macrophage derived foam cell differentiation, triglyceride metabolic process. KEGG pathway analysis showed that the three major enriched pathways were cholesterol metabolism, drug metabolism-cytochrome P450, PPAR signaling pathway. After qRT-PCR validation, we obtained 11 genes that were significant differentially expressed in the kidney tissues of DKD mice compared with control mice. (The mRNA expression levels of Aacs, Cpe, Cd36, Slc22a7, Slc1a4, Lpl, Cyp7b1, Akr1c14 and Apoh were declined, whereas Abcc4 and Gsta2 were elevated).
Conclusion: Our study, based on RNA-seq results, GEO databases and qRT-PCR, identified 11 significant dysregulated DEGs, which play an important role in lipid metabolism and the PPAR signaling pathway, which provide novel targets for diagnosis and treatment of DKD. ©2022 Zhao et al.

Entities:  

Keywords:  Bioinformatics analysis; Biomarker; Diabetic kidney disease (DKD); Differentially expressed genes (DEGs); RNA-seq

Year:  2022        PMID: 36157062      PMCID: PMC9504448          DOI: 10.7717/peerj.13932

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   3.061


  38 in total

Review 1.  High Throughput Sequencing and Assessing Disease Risk.

Authors:  Shannon M Rego; Michael P Snyder
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

2.  SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus.

Authors:  Gyu S Choi; Hye S Min; Jin J Cha; Ji E Lee; Jung Y Ghee; Ji A Yoo; Ki T Kim; Young S Kang; Sang Y Han; Yun S Bae; Sae R Lee; Jung Y Yoo; Sung H Moon; Soo J Lee; Dae R Cha
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-09-25       Impact factor: 4.222

3.  LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis.

Authors:  Quan Hong; Lu Zhang; Jia Fu; Divya A Verghese; Kinsuk Chauhan; Girish N Nadkarni; Zhengzhe Li; Wenjun Ju; Matthias Kretzler; Guang-Yan Cai; Xiang-Mei Chen; Vivette D D'Agati; Steven G Coca; Detlef Schlondorff; John C He; Kyung Lee
Journal:  J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 10.121

4.  APOH interacts with FTO to predispose to healthy thinness.

Authors:  Sandra J Hasstedt; Hilary Coon; Yuanpei Xin; Ted D Adams; Steven C Hunt
Journal:  Hum Genet       Date:  2015-12-28       Impact factor: 4.132

5.  Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell.

Authors:  Michael J MacDonald; Andrew D Smith; Noaman M Hasan; Grzegorz Sabat; Leonard A Fahien
Journal:  J Biol Chem       Date:  2007-08-27       Impact factor: 5.157

6.  Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels.

Authors:  Shinya Hasegawa; Kazuki Noda; Akina Maeda; Masaru Matsuoka; Masahiro Yamasaki; Tetsuya Fukui
Journal:  Mol Genet Metab       Date:  2012-08-29       Impact factor: 4.797

7.  Identification of Key Candidate Genes and Chemical Perturbagens in Diabetic Kidney Disease Using Integrated Bioinformatics Analysis.

Authors:  Zhuo Gao; Aishwarya S; Xiao-Mei Li; Xin-Lun Li; Li-Na Sui
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-07       Impact factor: 5.555

Review 8.  Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.

Authors:  Nur Samsu
Journal:  Biomed Res Int       Date:  2021-07-08       Impact factor: 3.411

9.  The origin of circulating CD36 in type 2 diabetes.

Authors:  M J Alkhatatbeh; A K Enjeti; S Acharya; R F Thorne; L F Lincz
Journal:  Nutr Diabetes       Date:  2013-02-04       Impact factor: 5.097

10.  Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.

Authors:  Soojeong Kim; Sung Jun Kim; Hye Eun Yoon; Sungjin Chung; Bum Soon Choi; Cheol Whee Park; Seok Joon Shin
Journal:  Int J Med Sci       Date:  2015-10-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.